Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 184

Similar articles for PubMed (Select 23514903)

1.

A reduction in anti-tuberculosis drug resistance after the implementation of the national "STOP TB" program in central Taiwan, 2003-2007.

Huang WC, Chen CH, Huang CC, Wu KM, Chiou CS, Lin CF, Chen JH, Shen GH.

Jpn J Infect Dis. 2013;66(2):89-95.

2.

Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.

Lai CC, Tan CK, Huang YT, Chou CH, Hung CC, Yang PC, Luh KT, Hsueh PR.

Clin Infect Dis. 2008 Oct 1;47(7):e57-63. doi: 10.1086/591702.

3.

Declining drug resistance of Mycobacterium tuberculosis isolates from elderly patients in Taiwan, 2000-2008.

Liu WL, Lai CC, Tan CK, Lin SH, Huang YT, Liao CH, Hsueh PR.

Eur J Clin Microbiol Infect Dis. 2010 Nov;29(11):1413-6. doi: 10.1007/s10096-010-1019-7. Epub 2010 Jul 22.

PMID:
20652344
4.

First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.

Shamaei M, Marjani M, Chitsaz E, Kazempour M, Esmaeili M, Farnia P, Tabarsi P, Amiri MV, Mirsaeidi M, Mansouri D, Masjedi MR, Velayati AA.

Int J Infect Dis. 2009 Sep;13(5):e236-40. doi: 10.1016/j.ijid.2008.11.027. Epub 2009 Mar 13.

5.

Increasing drug resistance of Mycobacterium tuberculosis isolates in a medical center in northern Taiwan.

Su WJ, Feng JY, Huang CC, Perng RP.

J Formos Med Assoc. 2008 Mar;107(3):259-64. doi: 10.1016/S0929-6646(08)60145-X.

PMID:
18400612
6.

[Prevalence and risk factors on the resistance related to second-line drugs among multi-drug resistant tuberculosis cases in Shanghai, China].

Li J, Zhang YY, Gui XH, Yuan ZA, Pan QC, Mei J, Shen X.

Zhonghua Liu Xing Bing Xue Za Zhi. 2012 Aug;33(8):796-8. Chinese.

PMID:
22967331
7.

Molecular characterization and second-line antituberculosis drug resistance patterns of multidrug-resistant Mycobacterium tuberculosis isolates from the northern region of South Africa.

Said HM, Kock MM, Ismail NA, Mphahlele M, Baba K, Omar SV, Osman AG, Hoosen AA, Ehlers MM.

J Clin Microbiol. 2012 Sep;50(9):2857-62. doi: 10.1128/JCM.00358-12. Epub 2012 May 30.

9.

The decline of high drug resistance rate of pulmonary Mycobacterium tuberculosis isolates from a southern Taiwan medical centre, 1996-2000.

Lu PL, Lee YW, Peng CF, Tsai JJ, Chen YH, Hwang KP, Chen TP.

Int J Antimicrob Agents. 2003 Mar;21(3):239-43.

PMID:
12636985
10.

Epidemiology of antituberculosis drug resistance in Saudi Arabia: findings of the first national survey.

Al-Hajoj S, Varghese B, Shoukri MM, Al-Omari R, Al-Herbwai M, Alrabiah F, Alrajhi AA, Abuljadayel N, Al-Thawadi S, Zumla A, Zignol M, Raviglione MC, Memish Z.

Antimicrob Agents Chemother. 2013 May;57(5):2161-6. doi: 10.1128/AAC.02403-12. Epub 2013 Mar 4.

11.

Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.

Becerra MC, Freeman J, Bayona J, Shin SS, Kim JY, Furin JJ, Werner B, Sloutsky A, Timperi R, Wilson ME, Pagano M, Farmer PE.

Int J Tuberc Lung Dis. 2000 Feb;4(2):108-14.

PMID:
10694087
12.

Application of quantitative second-line drug susceptibility testing at a multidrug-resistant tuberculosis hospital in Tanzania.

Mpagama SG, Houpt ER, Stroup S, Kumburu H, Gratz J, Kibiki GS, Heysell SK.

BMC Infect Dis. 2013 Sep 14;13:432. doi: 10.1186/1471-2334-13-432.

13.

Drug resistance pattern of mycobacterium tuberculosis complex at a medical center in central Taiwan, 2003-2007.

Yu CC, Chang CY, Liu CE, Shih LF, Hsiao JH, Chen CH.

J Microbiol Immunol Infect. 2010 Aug;43(4):285-90. doi: 10.1016/S1684-1182(10)60045-X.

PMID:
20688288
14.

Decline in rates of acquired multidrug-resistant tuberculosis after implementation of the directly observed therapy, short course (DOTS) and DOTS-Plus programmes in Taiwan.

Chien JY, Lai CC, Tan CK, Chien ST, Yu CJ, Hsueh PR.

J Antimicrob Chemother. 2013 Aug;68(8):1910-6. doi: 10.1093/jac/dkt103. Epub 2013 Apr 10.

15.

Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.

Park SK, Kim JH, Kang H, Cho JS, Smego RA Jr.

Int J Infect Dis. 2009 Mar;13(2):170-5. doi: 10.1016/j.ijid.2008.06.001. Epub 2008 Sep 2.

16.

Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.

Kim HR, Hwang SS, Kim HJ, Lee SM, Yoo CG, Kim YW, Han SK, Shim YS, Yim JJ.

Clin Infect Dis. 2007 Nov 15;45(10):1290-5. Epub 2007 Oct 15.

17.

Activity of twelve second-line antimicrobial agents against Mycobacterium tuberculosis in Taiwan.

Lu PL, Peng CF, Hwang JJ, Chen YH.

J Chemother. 2008 Apr;20(2):202-7.

PMID:
18467246
18.

First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia.

Tessema B, Beer J, Emmrich F, Sack U, Rodloff AC.

Int J Tuberc Lung Dis. 2012 Jun;16(6):805-11. doi: 10.5588/ijtld.11.0522. Epub 2012 Feb 29.

PMID:
22390880
19.

Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran.

Velayati AA, Masjedi MR, Farnia P, Tabarsi P, Ghanavi J, Ziazarifi AH, Hoffner SE.

Chest. 2009 Aug;136(2):420-5. doi: 10.1378/chest.08-2427. Epub 2009 Apr 6.

PMID:
19349380
20.

Drug resistance pattern of Mycobacterium tuberculosis in a university hospital in Taiwan, 1998-2002.

Liaw YS, Hsueh PR, Yu CJ, Wang SK, Yang PC, Luh KT.

J Formos Med Assoc. 2004 Sep;103(9):671-7.

PMID:
15361939
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk